Showing 34,798 results

Confidentiality, consent & medical ethics

HIV-infected people may face obligatory fingerprinting in Russia

Editor's pick
Russia Today
17 April 2014
Access to healthcare

NHS England agrees funding for life-saving hepatitis C drug

Editor's pick
NHS England (press release)
17 April 2014
Combatting stigma

A tale of two women dealing with HIV and self-stigma

Editor's pick
Key Correspondents
17 April 2014
New & experimental hepatitis C treatment

England: Patients with end-stage liver disease caused by hepatitis C to get new drug

Editor's pick
The Guardian
17 April 2014
Treatment outcomes & life expectancy

As a doctor, I’d rather have HIV than diabetes

Editor's pick
The Spectator
17 April 2014
PrEP

Px Wire: Long-Acting Injectables

Editor's pick
AVAC
17 April 2014
New & experimental hepatitis C treatment

BMS combination cures 90% of genotype 1b hepatitis C in 24 weeks

News
17 April 2014
Hepatitis C treatment

Sofosbuvir + ribavirin is safe and effective for people with hepatitis C who have advanced liver disease

News
16 April 2014
PrEP

Petition to Remove AHF's Michael Weinstein for "Party Drug" remark about PrEP

Editor's pick
Change.org
16 April 2014
Improving HIV care

Abolishing HIV in Rwanda

News
16 April 2014
Hepatitis B

Adding interferon to nucleoside antivirals may improve response for people with chronic hepatitis B

News
16 April 2014
Sexual health

When HIV is a turn-on

Editor's pick
Salon
16 April 2014
HIV prevention policy

‘Geographic lens’ may be key to HIV prevention

Editor's pick
Brown Daily Herald
16 April 2014
Harm reduction

Crimea: Russian Law Corners Drug Users

Editor's pick
Inter Press Service
16 April 2014

HIV update - 16th April 2014

April 2014
PrEP

Op-Ed: The Danger in Calling PrEP a "Party Drug"

Editor's pick
Out
15 April 2014
Support issues for children & young people

HIV: The power of positive thinking

Editor's pick
The Independent
15 April 2014
PEP

Few patients attend HIV clinic after ED visit for postexposure care

Editor's pick
Healio
15 April 2014
New & experimental HIV treatments

Bristol-Myers Squibb Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of Atazanavir Sulfate with Cobicistat for People Living with HIV-1

Editor's pick
Bristol-Myers Squibb press release
15 April 2014
HIV prevention policy

London election candidates urged to tackle HIV as numbers in the capital continue to increase

Editor's pick
NAT press release
15 April 2014
Transgender people

Issue Brief: Trans Populations and HIV: Time to End the Neglect

Editor's pick
amFAR
15 April 2014
Sexually transmitted infections tests & treatment

Awareness campaign shows signs of delaying onset of drug-resistant gonorrhea in UK

Editor's pick
Eurekalert Inf Dis
15 April 2014
New & experimental hepatitis C treatment

AbbVie 3-drug combination cures 92 to 96% of hepatitis C patients with cirrhosis

News
15 April 2014
New & experimental hepatitis C treatment

AbbVie 2-drug combination + ribavirin achieves 100% cure in previously untreated genotype 4 hepatitis C

News
14 April 2014